Cargando…
Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12
AIMS/HYPOTHESIS: Adult-onset type 1 diabetes, in which the 65 kDa isoform of GAD (GAD65) is a major autoantigen, has a broad clinical phenotype encompassing variable need for insulin therapy. This study aimed to evaluate whether autoantibodies against N-terminally truncated GAD65 more closely define...
Autores principales: | Achenbach, Peter, Hawa, Mohammed I., Krause, Stephanie, Lampasona, Vito, Jerram, Samuel T., Williams, Alistair J. K., Bonifacio, Ezio, Ziegler, Anette G., Leslie, R. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445455/ https://www.ncbi.nlm.nih.gov/pubmed/29619531 http://dx.doi.org/10.1007/s00125-018-4605-3 |
Ejemplares similares
-
Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
por: Williams, Alistair J.K., et al.
Publicado: (2015) -
Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2020) -
Autoantibodies to N-terminally Truncated GAD(65)(96-585): HLA Associations and Predictive Value for Type 1 Diabetes
por: Pöllänen, Petra M, et al.
Publicado: (2021) -
Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes
por: Gu, Yong, et al.
Publicado: (2021) -
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
por: Hawa, Mohammed I., et al.
Publicado: (2009)